Apotex Health Corp (APTX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 06-2026 | 06-2025 | |
| Sales | 847,979 | 1,142,289 |
| Cost of Goods | 426,768 | 399,891 |
| Gross Profit | 421,211 | 742,398 |
| Operating Expenses | 334,560 | 234,360 |
| Operating Income | 86,651 | 508,038 |
| Interest Expense | 54,805 | 46,536 |
| Other Income | -44,977 | -2,144 |
| Pre-tax Income | -13,131 | 459,358 |
| Income Tax | 25,214 | 96,658 |
| Net Income Continuous | -38,345 | 362,700 |
| Net Income | $-38,345 | $362,700 |
| EPS Basic Total Ops | -0.19 | 1.59 |
| EPS Basic Continuous Ops | -0.19 | N/A |
| EPS Diluted Total Ops | -0.19 | 1.59 |
| EPS Diluted Continuous Ops | -0.19 | N/A |
| EBITDA(a) | $79,325 | $533,811 |